Extended Continuous Positive Airway Pressure in Infants Born Preterm Decreases Intermittent Hypoxemia: A Secondary Analysis of a Randomized Controlled Trial.
Rachna R Mamidi, Mitzi Donabel A Go, Julia Harris et al.
✦ AI-curated · Sources linked
In 30 seconds
This secondary analysis of a randomized controlled trial evaluated the effects of extended continuous positive airway pressure (eCPAP) versus discontinued CPAP (dCPAP) on intermittent hypoxemia (IH) in stable preterm infants. The study found that eCPAP significantly reduced IH episodes (mean 57.6 vs 151.7 episodes per 24 hours, P < .0001) and increased mean oxygen saturation without supplemental oxygen.
Key findings
- Infants on eCPAP had 57.6 IH episodes per 24 hours compared to 151.7 for dCPAP.
- eCPAP resulted in a higher mean SpO2 without supplemental oxygen.
- eCPAP reduced cumulative IH duration and episodes across all thresholds.
- Functional residual capacity was significantly higher in the eCPAP group.
Why it matters
Reducing intermittent hypoxemia in preterm infants is crucial for their lung and brain development. eCPAP offers a nonpharmacologic approach to improve oxygenation and decrease hypoxemia episodes during a vulnerable period.